EyePoint EYPT 深 沪
等待开盘 09-24 09:30:00 美东时间
3.72
-0.350
-8.60%
华盛通- 最 高4.1818
- 今 开4.10
- 成交量 202.17万股
- 最 低 3.705
- 昨 收 4.07
- 总市值 3.21亿
- 52周最高 19.11
- 市盈率 静 --
- 换手率 2.35%
- 52周最低 3.415
- 委 比 25.92%
- 总股本 8621.21万
- 历史最高 39.40
- 量 比 0.37
- 振 幅 11.71%
- 历史最低 2.19
- 每 手 1
- 风险率 3.34%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Xenon Pharmaceuticals, Steel Dynamics, Nucor And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining around 150 points on Friday. Shares of Xenon Pharmaceuticals Inc (NASDAQ:XENE) fell sharply in pre-market trading after the company announced a temporary pause in enrollment for new patients in its ongoing psychiatry st...
09-18 20:01
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EyePoint, Inc. granted non-statutory stock options to a new employee outside its 2023 Long-Term Incentive Plan, totaling 3,000 shares, under NASDAQ Listing Rule 5635(c)(4). The options, exercisable at $3.66 per share, vest over four years with 25% on the first anniversary and the remainder in monthly installments. EyePoint, a biopharmaceutical company, is developing DURAVYU™, an investigational treatment for retinal diseases, currently in Phase 3...
09-16 11:00
美股大行评级 | 最高735美元！戴尔科技绩后获11家大行上调目标价；MongoDB绩后分歧大，9家上调；4家下调；派拓网络、GitLab、美敦力获多家大行上调目标价
今日重点评级关注：Tigress Financial：维持Liftoff Mobile"买入"评级，目标价从39美元升至41美元；奥本海默：维持SpaceX"跑赢大市"评级，目标价从250美元升至280美元
09-03 13:50
EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting
EyePoint, Inc. will participate in several upcoming conferences, including the Citi 2026 Biopharma Back to School Conference on September 9, 2026, the Cantor Global Healthcare Conference 2026 on September 10, 2026, and the Morgan Stanley Global Healthcare Conference on September 15, 2026. Fireside chats from these events will be available on the Company’s website. Additionally, EyePoint will present at The Retina Society 59th Annual Scientific Me...
09-02 11:00
EYPT ALERT: Investigation Launched into EyePoint, Inc., Investors are Encouraged to Contact KTMC Law Firm
RADNOR, Pa., Aug. 28, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of...
08-29 07:10
Nayax, Immatics, Moderna, Marvell Technology And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Nasdaq Composite gaining around 150 points on Tuesday. Shares of Nayax Ltd (NASDAQ:NYAX) rose sharply during Tuesday’s session after the payments company agreed to acquire smart parking technology provider IPS Group Inc. for $350 million in cash. Nayax will acquire ...
08-25 22:03
A股盘前市场要闻速递（2026-08-19）
小程序：A股盘前市场要闻速递 重要新闻 1. 重大突破，我国首次实现火箭陆地回收 今天（8月19日），朱雀三号遥二运载火箭在东风商业航天创新试验区发射升空，火箭...
08-19 09:02
These Analysts Slash Their Forecasts On EyePoint
EyePoint Inc. (NASDAQ:EYPT) on Monday released topline results from its pivotal Phase 3 LUGANO clinical trial evaluating DURAVYU for the treatment of wet age-related macular degeneration. While key secondary endpoints showed significant clinical progress, the study failed to meet its primary visual ...
08-19 00:11
EyePoint rebounds after selloff despite multiple downgrades
After losing more than 65% in the previous session following a late-stage trial setback for its lead asset, Duravyu, EyePoint added 7% in morning trading despite facing multiple downgrades on Wall Str...
08-18 22:17
贝达药业(300558.SZ)：合作伙伴公布DURAVYU治疗湿性年龄相关性黄斑变性开展的两项关键Ⅲ期临床试验中的首项试验数据
格隆汇8月18日丨贝达药业(300558.SZ)公布，公 司 合作伙伴EyePointPharmaceuticals, Inc.（NASDAQ：EYPT，简称...
08-18 20:48
